Yoko Ikeda

Title: Yoko Ikeda: Innovator in Glaucoma Risk Assessment

Introduction

Yoko Ikeda is a prominent inventor based in Kyoto, Japan. She has made significant contributions to the field of medical diagnostics, particularly in the assessment of glaucoma risk. Her innovative approach has the potential to enhance preventive measures and treatment options for individuals at risk of this eye condition.

Latest Patents

Yoko Ikeda holds a patent for a method titled "Method for determination of progression risk of glaucoma." This method involves detecting an allele and/or a genotype of a single nucleotide polymorphism located on a specific base of a base sequence in a sample from a subject. By comparing the detected allele and/or genotype with high-risk alleles, the method allows for the determination of the level of progressive risk of glaucoma. This innovation enables sample donors to take preventive measures or receive appropriate treatments based on their risk assessment.

Career Highlights

Throughout her career, Yoko Ikeda has worked with notable companies, including Santen Pharmaceutical Co., Ltd. Her work has focused on advancing medical technologies and improving patient outcomes through innovative diagnostic methods.

Collaborations

Yoko has collaborated with esteemed colleagues such as Shigeru Kinoshita and Kei Tashiro. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of glaucoma research.

Conclusion

Yoko Ikeda's contributions to glaucoma risk assessment exemplify the impact of innovation in medical diagnostics. Her patented method not only enhances understanding of glaucoma risks but also empowers individuals to take proactive steps in managing their eye health.